Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · Real-Time Price · USD
5.81
+0.13 (2.20%)
Dec 19, 2025, 2:59 PM EST - Market open
Ardelyx Market Cap
Ardelyx has a market cap or net worth of $1.41 billion as of December 19, 2025. Its market cap has increased by 8.27% in one year.
Market Cap
1.41B
Enterprise Value
1.37B
1-Year Change
8.27%
Ranking
Category
Stock Price
$5.81
Market Cap Chart
Since June 19, 2014, Ardelyx's market cap has increased from $242.70M to $1.41B, an increase of 481.16%. That is a compound annual growth rate of 16.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 1.38B | 14.92% |
| Dec 31, 2024 | 1.20B | -16.56% |
| Dec 29, 2023 | 1.44B | 169.38% |
| Dec 30, 2022 | 534.30M | 330.89% |
| Dec 31, 2021 | 124.00M | -78.76% |
| Dec 31, 2020 | 583.90M | 23.68% |
| Dec 31, 2019 | 472.10M | 324.55% |
| Dec 31, 2018 | 111.20M | -64.55% |
| Dec 29, 2017 | 313.70M | -53.30% |
| Dec 30, 2016 | 671.70M | 42.82% |
| Dec 31, 2015 | 470.30M | 34.29% |
| Dec 31, 2014 | 350.20M | 44.29% |
| Jun 19, 2014 | 242.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |